|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02179 RECBIO-B
Nominal 
7.800 +0.320 (+4.278%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (464,825) | (638,072) | (579,541) | (472,921) |
| Net Cash from / (used in) Investing Activities | -- | (279,042) | 9,424 | (378,427) | 68,704 |
| Net Cash from / (used in) Financing Activities | -- | 218,055 | 275,275 | 839,437 | 1,229,448 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (525,812) | (353,373) | (118,531) | 825,231 |
| Cash & Cash Equivalents at beginning of period | -- | 834,983 | 1,169,092 | 1,172,562 | 355,821 |
| Effect of Foreign Exchange Rate Changes | -- | 9,869 | 19,264 | 115,061 | (8,490) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 319,040 | 834,983 | 1,169,092 | 1,172,562 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -340,653 |
| %Change | 36.734% |
| EPS / (LPS) | RMB -0.710 |
| NBV Per Share (¥) | RMB 0.368 |